P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID-19 PANDEMIC.
Main Authors: | T. Tolstykh, E. Baryakh, D. Ivanova, T. Chudnova, M. Misyurina, E. Medvedovskaya, M. Litvinenko, Y. Polyakov, O. Kochneva |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849304.53054.9c |
Similar Items
-
P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19.
by: D. Ivanova, et al.
Published: (2022-06-01) -
PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS.
by: E. Baryakh, et al.
Published: (2022-06-01) -
P1576: NOVEL APPROACHES TO MANAGEMENT OF COVID-19 IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
by: Tatiana Chudnova, et al.
Published: (2023-08-01) -
PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS
by: O. Kochneva, et al.
Published: (2022-06-01) -
P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
by: T. Chudnova, et al.
Published: (2022-06-01)